Biogen presents at Global Healthcare Conference

American Pharmacy News Reports | Feb 15, 2017
Those who were unable to participate in the live event are encouraged to visit www.biogen.com/investors.
Those who were unable to participate in the live event are encouraged to visit www.biogen.com/investors. | File photo
Biotechnology group Biogen presented this afternoon at the Leerink Partners' 6th Annual Global Healthcare Conference in New York.
Those who were unable to participate in the live event are encouraged to visit www.biogen.com/investors. A taped version of the webcast is available.
A longtime Biologics manufacturer, Biogen's portfolio includes treatments for spinal muscular atrophy. It is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis.
More News

Those with preexisting health conditions may experience a different immune response to the COVID-19 vaccination.

People CDC releases COVID-19 guidance for those with health conditions Jan 10, 2021

Novavax is the latest COVID-19 vaccine to enter Phase III clinical trials.

Innovation Fifth vaccine set to enter Phase III clinical trials Jan 3, 2021

Regulatory CENTENE: Completes Acquisition of PANTHERx Rare Pharmacy (PANTHERx) Dec 31, 2020

Industry NHA: Creates Partnership, Path for Accredited Immunization Training for Pharmacy Technicians Ahead of New Vaccines Dec 31, 2020

Industry TRANQUILMONEY: Releases PharmTracker for Independent Pharmacies, Small and Medium Pharmacy Chains Dec 26, 2020

Industry MITSUBISHI TANABE PHARMA AMERICA: Announces Initiation of Open-Label Extension Study of Oral Edaravone in ALS Dec 22, 2020